956541241	956541241	CD	B-NP	O
|	|	NN	I-NP	O
HMC	HMC	NN	I-NP	O
|	|	NN	I-NP	O
29831803	29831803	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7855543	7855543	CD	B-NP	O
|	|	CC	I-NP	O
7/17/2005	7/17/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/15/2005	5/15/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/6/2005	4/6/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
FRICKS	FRICKS	NN	B-NP	O
,	,	,	O	O
RAFAEL	RAFAEL	NN	B-NP	O
542-69-73-0	542-69-73-0	CD	I-NP	O
Louislong	Louislong	NNP	I-NP	O
Flint	Flint	NNP	I-NP	O
Mahis	Mahis	NNP	I-NP	O
Ha	Ha	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
VAS	VAS	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/1/05	9/1/05	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WIKOFF	WIKOFF	NNP	B-NP	O
,	,	,	O	O
GERARDO	GERARDO	NNP	B-NP	O
ELDRIDGE	ELDRIDGE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Headache	Headache	NNP	I-NP	I-protein
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ASA	ASA	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
81	81	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PEPCID	PEPCID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FAMOTIDINE	FAMOTIDINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
HEPARIN	HEPARIN	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

OXYCODONE	OXYCODONE	IN	B-PP	O
5-10	5-10	CD	B-NP	B-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
Q4H	Q4H	NNP	I-NP	I-DNA
PRN	PRN	NNP	I-NP	I-DNA
Pain	Pain	NNP	I-NP	I-DNA
ZOCOR	ZOCOR	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

NEURONTIN	NEURONTIN	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
TRICOR	TRICOR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
48	48	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
66	66	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Do	Do	NNP	B-NP	O
not	not	RB	B-VP	O
hold	hold	VB	I-VP	O
even	even	RB	B-SBAR	O
if	if	IN	I-SBAR	O
pt	pt	NN	B-NP	O
.	.	.	O	O

is	be	VBZ	B-VP	O
NPO	NPO	NN	B-NP	B-protein
.	.	.	O	O

Thanks	Thank	NNS	B-NP	O
ARANESP	ARANESP	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DARBEPOETIN	DARBEPOETIN	NNP	I-NP	O
ALFA	ALFA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
ordering	order	VBG	B-VP	O
:	:	:	O	O
Renal	Renal	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
Last	Last	JJ	I-NP	O
known	know	VBN	I-NP	O
Hgb	Hgb	NN	I-NP	B-protein
level	level	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
order	order	NN	B-NP	O
:	:	:	O	O
6.9	6.9	CD	B-NP	O
g/dL	g/dL	NN	I-NP	O
on	on	IN	B-PP	O
2/30/05	2/30/05	CD	B-NP	O
at	at	IN	B-PP	O
PH	PH	NN	B-NP	O
Diagnosis	Diagnosis	NN	I-NP	O
:	:	:	O	O
Anemia	Anemia	NN	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
Chronic	Chronic	NNP	I-NP	O
Illness	Illness	NNP	I-NP	O
285.29	285.29	CD	I-NP	O
Treatment	Treatment	NNP	I-NP	O
Cycle	Cycle	NNP	I-NP	O
:	:	:	O	O
Maintenance	Maintenance	NNP	B-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8	8	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
if	if	IN	B-SBAR	O
BS	BS	NN	B-NP	B-protein
<	<	SYM	O	I-protein
100	100	CD	B-NP	I-protein
please	please	NN	I-NP	I-protein
give	give	VBP	B-VP	O
4U	4U	NN	B-NP	B-protein
novolog	novolog	NN	I-NP	I-protein
NOVOLOG	NOVOLOG	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
LINEZOLID	LINEZOLID	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
for	for	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
;	;	:	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
platelets	platelet	NNS	B-NP	B-cell_type
checked	check	VBD	B-VP	O
q	q	NN	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
tyramine-containing	tyramine-containing	JJ	I-NP	O
foods	food	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-PP	O
tolerated	tolerate	VBN	B-NP	O
heel	heel	NN	I-NP	O
weight	weight	NN	I-NP	O
bearing	bear	VBG	B-VP	O
only	only	RB	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Amemiya	Amemiya	NNP	I-NP	O
317-001-4753	317-001-4753	CD	I-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
hosptial	hosptial	JJ	B-NP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
10/16	10/16	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
non	non	AFX	B-NP	O
healing	heal	VBG	B-VP	O
RLE	RLE	NNP	B-NP	O
TMA	TMA	NNP	I-NP	O
stump	stump	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
htn	htn	NN	I-NP	O
dm	dm	NN	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
cri	cri	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
arf	arf	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
acute	acute	JJ	I-NP	B-protein
renal	renal	JJ	I-NP	I-protein
failure	failure	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
anemia	anemia	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
anemia	anemia	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
hyperchol	hyperchol	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
elevated	elevated	JJ	I-NP	I-protein
cholesterol	cholesterol	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
left	leave	VBD	B-VP	O
toe	toe	NN	B-NP	O
digit	digit	NN	I-NP	O
amputation	amputation	NN	I-NP	O
retinopathy	retinopathy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
retinopathy	retinopathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
52-year-old	52-year-old	JJ	B-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
long	long	RB	B-ADVP	O
standing	stand	VBG	B-VP	O
diabetes	diabete	NNS	B-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
undergone	undergo	VBN	I-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
popliteal	popliteal	NN	I-NP	O
to	to	TO	B-PP	O
posterior	posterior	JJ	B-NP	O
tibial	tibial	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
with	with	IN	B-PP	O
transmetatarsal	transmetatarsal	JJ	B-NP	O
amputation	amputation	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
diabetic	diabetic	JJ	I-NP	O
foot	foot	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
vascular	vascular	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
revascularization	revascularization	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
TMA	TMA	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
healed	heal	VBN	I-VP	O
with	with	IN	B-PP	O
most	most	JJS	B-NP	O
recent	recent	JJ	I-NP	O
debridement	debridement	NN	I-NP	O
11/9/05	11/9/05	CD	I-NP	O
.	.	.	O	O

Returned	Return	VBN	B-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
to	to	TO	B-PP	O
103	103	CD	B-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
swelling	swelling	NN	B-NP	O
and	and	CC	I-NP	O
drainage	drainage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
R	R	NN	I-NP	B-DNA
TMA	TMA	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
no	no	DT	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
Insulin-dependent	Insulin-dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
nephropathy	nephropathy	NN	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
retinopathy	retinopathy	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
arthritis	arthritis	NN	B-NP	O
,	,	,	O	O
pancreatitis	pancreatitis	NN	B-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

PSH	PSH	NN	B-NP	O
1980	1980	CD	I-NP	O
pancreatic	pancreatic	JJ	I-NP	O
debridement	debridement	NN	I-NP	O
,	,	,	O	O
5/20	5/20	CD	B-NP	O
right	right	JJ	I-NP	O
ring	ring	NN	I-NP	O
finger	finger	NN	I-NP	O
debridement	debridement	NN	I-NP	O
,	,	,	O	O
4/10	4/10	CD	B-NP	O
left	leave	VBD	B-VP	O
fourth	fourth	JJ	B-NP	O
and	and	CC	I-NP	O
fifth	fifth	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
,	,	,	O	O
6/13	6/13	CD	B-NP	O
right	right	JJ	I-NP	O
third	third	JJ	I-NP	O
and	and	CC	I-NP	O
fifth	fifth	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
and	and	CC	O	O
10/20	10/20	CD	B-NP	O
right	right	JJ	I-NP	O
popliteal-posterior	popliteal-posterior	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
and	and	CC	O	O
completion	completion	NN	B-NP	O
TMA	TMA	NN	I-NP	O
.	.	.	O	O

8/13	8/13	CD	B-NP	O
,	,	,	I-NP	O
1/9	1/9	CD	I-NP	O
TMA	TMA	NN	I-NP	O
debridement	debridement	NN	I-NP	O
Meds	Meds	NNP	I-NP	O
Allopurinol	Allopurinol	NNP	I-NP	O
300	300	CD	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	B-DNA
81	81	CD	I-NP	I-DNA
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
Chlorothiadone	Chlorothiadone	NN	B-NP	B-protein
12.5	12.5	CD	I-NP	I-protein
,	,	,	O	O
colace	colace	NN	B-NP	O
,	,	,	O	O
Fe	Fe	NN	B-NP	O
325	325	CD	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
Lopressor	Lopressor	NN	I-NP	I-protein
100	100	CD	B-NP	I-protein
q6	q6	NN	I-NP	I-protein
,	,	,	O	O
Oxycodone	Oxycodone	NN	B-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
300	300	CD	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
Tricor	Tricor	NNP	B-NP	O
48	48	CD	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
60	60	CD	B-NP	O
qhs	qh	NNS	I-NP	O
Aranesp	Aranesp	VBP	B-VP	O
40	40	CD	B-NP	O
qwk	qwk	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

Exam	Exam	NNP	B-NP	O
98.9	98.9	CD	I-NP	O
74139/62	74139/62	CD	I-NP	O
18	18	CD	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
r/a	r/a	NN	I-NP	O
looks	look	VBZ	B-VP	O
well	well	RB	B-ADVP	O
no	no	DT	B-NP	O
distress	distress	NN	I-NP	O
chest	chest	NN	I-NP	O
clear	clear	JJ	I-NP	O
cor	cor	NN	I-NP	O
rrr	rrr	NN	I-NP	O
abdomen	abdomen	NN	I-NP	O
prior	prior	JJ	I-NP	O
midline	midline	NN	I-NP	O
incision	incision	NN	I-NP	O
soft	soft	JJ	I-NP	O
and	and	CC	I-NP	O
non-tender	non-tender	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
fem	fem	VBP	B-VP	O
pop	pop	NN	B-NP	B-DNA
dp	dp	NN	I-NP	I-DNA
pt	pt	NN	I-NP	I-DNA
graft	graft	NN	I-NP	I-DNA
L	L	NN	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
+	+	SYM	B-NP	I-DNA
--	--	:	O	I-DNA
dop	dop	NN	B-NP	I-DNA
dop	dop	NN	I-NP	I-DNA
R	R	NN	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
+	+	SYM	B-NP	I-DNA
--	--	:	O	I-DNA
dop	dop	NN	B-NP	I-DNA
dop	dop	NN	I-NP	I-DNA
dop	dop	NN	I-NP	I-DNA
R	R	NN	I-NP	I-DNA
TMA	TMA	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
granulation	granulation	NN	I-NP	O
tissue	tissue	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fluctuance	fluctuance	NN	I-NP	O
R	R	NN	I-NP	O
foot	foot	NN	I-NP	O
and	and	CC	O	O
distal	distal	JJ	B-NP	O
leg	leg	NN	I-NP	O
much	much	JJ	I-NP	O
warmer	warmer	NN	I-NP	O
than	than	IN	B-SBAR	O
left	leave	VBD	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
motor	motor	NN	I-NP	O
ok	ok	NN	I-NP	O
.	.	.	O	O

sensory	sensory	JJ	B-NP	O
diminished	diminish	VBN	B-VP	O
.	.	.	O	O

3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
CXR	CXR	NN	I-NP	O
ok	ok	NN	I-NP	O
EKG	EKG	NNP	I-NP	O
ok	ok	NNP	I-NP	O
R	R	NNP	I-NP	O
Foot	Foot	NNP	I-NP	O
plain	plain	JJ	I-NP	O
films	film	NNS	I-NP	O
--	--	:	O	O
possible	possible	JJ	B-NP	O
osteo	osteo	NN	I-NP	O
of	of	IN	B-PP	O
1st	1st	JJ	B-NP	O
,	,	,	I-NP	O
4th	4th	JJ	I-NP	O
and	and	CC	I-NP	O
5th	5th	JJ	I-NP	O
metatarsal	metatarsal	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
prelim	prelim	NN	I-NP	O
read	read	VBN	B-VP	O
by	by	IN	B-PP	O
ED	ED	NNP	B-NP	O
Rads	Rads	NNP	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Vascular	Vascular	JJ	B-ADJP	O
with	with	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O
of	of	IN	B-PP	O
non-healing	non-healing	JJ	B-NP	B-DNA
TMA	TMA	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
&	&	CC	I-NP	O
osteo	osteo	NN	I-NP	O
despite	despite	IN	B-PP	O
apparent	apparent	JJ	B-NP	O
adequate	adequate	JJ	I-NP	O
revascularization	revascularization	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
foot	foot	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
R	R	NN	B-NP	O
foot	foot	NN	I-NP	O
,	,	,	O	O
Triple	Triple	NNP	B-NP	O
Abx	Abx	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Vanc/Levo/Flagyl	Vanc/Levo/Flagyl	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
NPO/IVF	NPO/IVF	NN	B-NP	B-protein
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
BKA	BKA	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	B-protein
.	.	.	O	O

DM	DM	NN	B-NP	O
management	management	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
optimized	optimize	VBN	B-VP	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
provided	provide	VBN	B-NP	O
DM	DM	NN	I-NP	O
teaching	teaching	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
SG6	SG6	NN	B-NP	B-protein
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RLE	RLE	NN	I-NP	O
revealing	reveal	VBG	B-VP	O
extensive	extensive	JJ	B-NP	O
OM	OM	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
3rd	3rd	NN	I-NP	O
>	>	SYM	B-VP	O
4th	4th	JJ	B-NP	O
metatarsal	metatarsal	JJ	I-NP	O
heads	head	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cuboid	cuboid	JJ	I-NP	O
,	,	,	O	O
cunioform	cunioform	VB	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
calcaneuos	calcaneuo	NNS	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
MRSA	MRSA	NN	B-NP	B-protein
from	from	IN	B-PP	O
6/7	6/7	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
remaining	remain	VBG	I-NP	I-protein
blood	blood	NN	I-NP	I-protein
cultures	culture	NNS	I-NP	I-protein
x	x	SYM	B-NP	I-protein
2	2	CD	B-NP	I-protein
over	over	IN	I-NP	O
48	48	CD	I-NP	O
hours	hour	NNS	I-NP	O
remained	remain	VBD	B-VP	O
negetive	negetive	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
WBC	WBC	NN	I-NP	O
never	never	RB	B-ADVP	O
rose	rise	VBD	B-VP	O
above	above	IN	B-PP	O
7.8	7.8	CD	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
left	left	JJ	I-NP	O
shift	shift	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
foot	foot	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
exam	exam	NN	B-NP	O
revealng	revealng	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
diabetic	diabetic	JJ	I-NP	O
dermopathy	dermopathy	NN	I-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
open	open	JJ	I-NP	O
wound	wound	NN	I-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
granulation	granulation	NN	I-NP	O
tissue	tissue	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fluctuance	fluctuance	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
warmth	warmth	NN	I-NP	O
or	or	CC	I-NP	O
TTP	TTP	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
dc	dc	NN	B-NP	B-cell_type
'd	'd	MD	B-VP	O
and	and	CC	O	O
will	will	MD	B-VP	O
return	return	VB	I-VP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
AKA	AKA	NN	I-NP	O
4/12	4/12	CD	I-NP	O
after	after	IN	B-SBAR	O
his	his	PRP$	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
resolves	resolve	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
linizolid	linizolid	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
HD4	HD4	NN	B-NP	B-protein
after	after	IN	B-PP	O
an	an	DT	B-NP	O
unremarkable	unremarkable	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
fit	fit	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
dc	dc	NN	B-NP	B-cell_type
'd	'd	MD	B-VP	O
home	home	VB	I-VP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
for	for	IN	B-PP	O
WTD	WTD	NN	B-NP	O
dressing	dressing	NN	I-NP	O
changes	change	NNS	I-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
AFVSS	AFVSS	NN	B-NP	O
,	,	,	O	O
tolerating	tolerate	VBG	B-VP	O
an	an	DT	B-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ambulating	ambulate	VBG	B-VP	O
heel	heel	NN	B-NP	O
weight	weight	NN	I-NP	O
bearing	bear	VBG	B-VP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
WTD	WTD	NN	B-NP	O
dressing	dressing	NN	I-NP	O
changes	change	NNS	I-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

Keep	Keep	NN	B-NP	O
leg	leg	NN	I-NP	O
elevated	elevate	VBN	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
the	the	DT	B-NP	O
linizolid	linizolid	JJ	I-NP	O
x	x	NN	I-NP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
;	;	:	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
qweekly	qweekly	RB	B-NP	O
CBC	CBC	NNP	I-NP	O
check	check	NN	I-NP	O
for	for	IN	B-PP	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

should	should	MD	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
increasing	increase	VBG	I-VP	O
leg	leg	NN	B-NP	O
or	or	CC	I-NP	O
arm	arm	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
groin	groin	NN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
T	T	NN	B-NP	B-cell_line
>	>	SYM	B-VP	I-cell_line
101.5	101.5	CD	B-NP	I-cell_line
,	,	,	O	O
redness/puss	redness/pus	VBZ	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
incision	incision	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
stroke	stroke	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
eg	eg	NN	I-NP	O
HA	HA	NN	I-NP	O
,	,	,	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
vision/speech	vision/speech	NN	B-NP	O
,	,	,	O	O
unilateral	unilateral	JJ	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
motor/sensation	motor/sensation	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
return	return	VB	I-VP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
AKA	AKA	NN	I-NP	O
10/16	10/16	CD	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WOLL	WOLL	NNP	B-NP	O
,	,	,	O	O
COREY	COREY	NNP	B-NP	O
SHIRLEY	SHIRLEY	NNP	I-NP	O
H.	H.	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EF47	EF47	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/1/05	9/1/05	CD	I-NP	O
@	@	SYM	B-NP	O
08	08	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

